Pitcairn’s MetLife MET Stock Holding History

Pitcairn’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,341	Closed	-$1.1M	–	341
2025 Q3	$1.1M	Sell	13,341 -3,848	-22%	-$303K	0.09%	204
2025 Q2	$1.38M	Sell	17,189 -7,432	-30%	-$574K	0.09%	209
2025 Q1	$1.98M	Buy	24,621 +19,521	+383%	+$1.62M	0.12%	155
2024 Q4	$418K	Sell	5,100 -13	-0.3%	-$1.08K	0.02%	478
2024 Q3	$422K	Sell	5,113 -1,335	-21%	-$99.7K	0.02%	488
2024 Q2	$453K	Buy	6,448 +697	+12%	+$49.8K	0.03%	471
2024 Q1	$426K	Buy	5,751 +304	+6%	+$21.2K	0.03%	474
2023 Q4	$360K	Sell	5,447 -82	-1%	-$5.13K	0.03%	493
2023 Q3	$348K	Buy	5,529 +955	+21%	+$59.5K	0.03%	454
2023 Q2	$259K	Sell	4,574 -1,531	-25%	-$85K	0.02%	554
2023 Q1	$354K	Buy	6,105 +769	+14%	+$51.9K	0.03%	452
2022 Q4	$386K	Buy	5,336 +414	+8%	+$29.7K	0.04%	385
2022 Q3	$299K	Buy	4,922 +173	+4%	+$11.1K	0.03%	431
2022 Q2	$298K	Sell	4,749 -169	-3%	-$11.2K	0.03%	436
2022 Q1	$346K	Sell	4,918 -188	-4%	-$12.7K	0.03%	466
2021 Q4	$319K	Sell	5,106 -103	-2%	-$6.46K	0.02%	502
2021 Q3	$321K	Sell	5,209 -58	-1%	-$3.49K	0.02%	471
2021 Q2	$315K	Sell	5,267 -131	-2%	-$8.3K	0.02%	487
2021 Q1	$328K	Buy	5,398 +253	+5%	+$14K	0.02%	459
2020 Q4	$242K	Buy	+5,145	New	+$223K	0.02%	512
2020 Q1	–	Sell	-9,873	Closed	-$503K	–	501
2019 Q4	$503K	Sell	9,873 -194	-2%	-$9.37K	0.05%	254
2019 Q3	$475K	Buy	10,067 +430	+4%	+$20.5K	0.05%	252
2019 Q2	$479K	Buy	9,637 +1,729	+22%	+$81.3K	0.05%	251
2019 Q1	$337K	Sell	7,908 -15,494	-66%	-$685K	0.04%	320
2018 Q4	$961K	Sell	23,402 -1,193	-5%	-$51.2K	0.11%	115
2018 Q3	$1.15M	Buy	24,595 +3,460	+16%	+$158K	0.12%	109
2018 Q2	$922K	Buy	21,135 +106	+0.5%	+$4.94K	0.1%	132
2018 Q1	$965K	Sell	21,029 -4,130	-16%	-$200K	0.1%	126
2017 Q4	$1.27M	Sell	25,159 -285	-1%	-$15K	0.13%	105
2017 Q3	$1.32M	Sell	25,444 -7,515	-23%	-$366K	0.15%	95
2017 Q2	$1.61M	Sell	32,959 -12,492	-27%	-$579K	0.19%	68
2017 Q1	$2.14M	Sell	45,451 -1,831	-4%	-$87.3K	0.26%	50
2016 Q4	$2.27M	Sell	47,282 -2,513	-5%	-$115K	0.28%	50
2016 Q3	$1.97M	Buy	49,795 +4,678	+10%	+$176K	0.25%	58
2016 Q2	$1.6M	Buy	45,117 +14,201	+46%	+$554K	0.21%	71
2016 Q1	$1.21M	Buy	30,916 +4,716	+18%	+$176K	0.15%	111
2015 Q4	$1.13M	Sell	26,200 -3,819	-13%	-$168K	0.13%	127
2015 Q3	$1.26M	Buy	30,019 +20,224	+206%	+$945K	0.17%	97
2015 Q2	$489K	Buy	+9,795	New	+$464K	0.06%	254
2015 Q1	–	Sell	-4,341	Closed	-$209K	–	500
2014 Q4	$209K	Buy	4,341 +28	+0.6%	+$1.33K	0.02%	449
2014 Q3	$206K	Hold	4,313	–	–	0.02%	446
2014 Q2	$214K	Sell	4,313 -241	-5%	-$11.3K	0.02%	433
2014 Q1	$214K	Sell	4,554 -411	-8%	-$18.9K	0.02%	436
2013 Q4	$238K	Sell	4,965 -183	-4%	-$8.2K	0.03%	432
2013 Q3	$216K	Buy	+5,148	New	+$222K	0.03%	425

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pitcairn's MET Position: Q4 2025 in Review

Pitcairn sold out of MetLife (MET) in Q4 2025, closing a stake of 13,341 shares — an estimated $1.1M sold.

Pitcairn first reported a position in MET in Q3 2013 and held it in 45 quarters. The position peaked at $2.27M in Q4 2016. 1,445 funds tracked by Wall St. Rank hold MET as of Q4 2025.

Pitcairn reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
Pitcairn sold 13,341 MetLife shares in Q4 2025, an estimated $1.1M.
Pitcairn first reported a position in MetLife in Q3 2013 and held it in 45 quarters.
Pitcairn's MetLife position peaked at $2.27M in Q4 2016.
1,445 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.